Table 2. MRI findings, CSF and Laboratory features of our patients.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Spinal MRI | Cervicomedullary junction to T8 | T1 and L1 | T3 to conus | T1 to conus | T7-T8, T8-T9 and conus |
| LETM | Yes | No | Yes | Yes | No |
| Gadolinium enhancement | Yes | No | No | No | Yes |
| Brain MRI | Normal | Nonspecifica | NA | Normal | NA |
| CSF | + | + | + | + | + |
| Proteinorachia (mg/dl) | 140 | 58 | 80 | 113 | 65 |
| Glycorachia (mg/dl) | 60 | 48 | 70 | 12 | 67 |
| Leukocytes (/mm3) | 130 (lymp) | 10 (lymp) | 30 (lymp) | 100 (PMN) | 20 (lymp) |
| OCB | Negative | NA | Negative | NA | NA |
| ANA | 1/1280 | 1/160 | 1/160 | 1/1280 | 1/1280 |
| Anti-dsDNA | + | Negative | + | + | + |
| C3-C4 levels | Low | Low | Normal | Low | Low |
| Antiphospholipid-ab | LA, aCL | aCL, a-β2GP1 | Negative | Negative | LA, aCL |
| AQP4-ab | Negative | NA | Negative | NA | NA |
Abbreviations: a-β2GP1, anti-β2 glycoprotein-I antibody; aCL, anticardiolipin antibody; ANA, antinuclear antibodies; AQP4-ab, aquaporin-4 antibodies; Anti-dsDNA, anti-double-stranded DNA; CSF, cerebrospinal fluid; LA, lupus anticoagulant; LETM, longitudinal extensive transverse myelitis; lymp, lymphocytes; MRI, magnetic resonance imaging; NA, not available; OCB, oligoclonal bands; PMN, polymorphonuclear cells; T, thoracic.
a
Brain MRI with nonspecific subcortical isolated lesion.